DK0754234T3 - DNA der koder precursor for interleukin-1beta-omdannende enzymbeslægtet cycteinproteinase II (ICErel-II) - Google Patents
DNA der koder precursor for interleukin-1beta-omdannende enzymbeslægtet cycteinproteinase II (ICErel-II)Info
- Publication number
- DK0754234T3 DK0754234T3 DK95914256T DK95914256T DK0754234T3 DK 0754234 T3 DK0754234 T3 DK 0754234T3 DK 95914256 T DK95914256 T DK 95914256T DK 95914256 T DK95914256 T DK 95914256T DK 0754234 T3 DK0754234 T3 DK 0754234T3
- Authority
- DK
- Denmark
- Prior art keywords
- icerel
- cdna
- recombinant
- 1beta
- proteinase
- Prior art date
Links
- 102100035904 Caspase-1 Human genes 0.000 title 1
- 108090000426 Caspase-1 Proteins 0.000 title 1
- 101000622007 Crotalus adamanteus Snake venom metalloproteinase adamalysin-2 Proteins 0.000 title 1
- 102000016736 Cyclin Human genes 0.000 title 1
- 108050006400 Cyclin Proteins 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
- 108020004635 Complementary DNA Proteins 0.000 abstract 6
- 238000010804 cDNA synthesis Methods 0.000 abstract 6
- 239000002299 complementary DNA Substances 0.000 abstract 6
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 230000006870 function Effects 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/225,487 US6110701A (en) | 1994-04-08 | 1994-04-08 | DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
| PCT/CA1995/000188 WO1995027793A1 (en) | 1994-04-08 | 1995-04-04 | DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0754234T3 true DK0754234T3 (da) | 1999-11-29 |
Family
ID=22845077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95914256T DK0754234T3 (da) | 1994-04-08 | 1995-04-04 | DNA der koder precursor for interleukin-1beta-omdannende enzymbeslægtet cycteinproteinase II (ICErel-II) |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6110701A (da) |
| EP (1) | EP0754234B1 (da) |
| JP (1) | JP3750136B2 (da) |
| AT (1) | ATE182176T1 (da) |
| CA (1) | CA2187161C (da) |
| DE (1) | DE69510782T2 (da) |
| DK (1) | DK0754234T3 (da) |
| ES (1) | ES2136285T3 (da) |
| GR (1) | GR3031468T3 (da) |
| WO (1) | WO1995027793A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0770141A4 (en) * | 1994-06-23 | 1998-03-04 | Human Genome Sciences Inc | INTERLEUKIN-1-BETA-CONVERTING-ENZYME-LIKE APOPTOSIS PROTEASE-1 AND 2 |
| FR2723378B1 (fr) * | 1994-08-02 | 1996-10-31 | Roussel Uclaf | Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications |
| WO1996026280A1 (en) * | 1995-02-21 | 1996-08-29 | Basf Aktiengesellschaft | NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME |
| US6121018A (en) * | 1997-03-27 | 2000-09-19 | Smithkline Beecham Corporation | Interleukin-1β converting enzyme like apoptosis protease-10 |
| PL366134A1 (en) | 2000-06-15 | 2005-01-24 | Smithkline Beecham Corporation | Method for preparing a physiologically active il-18 polypeptide |
| CN115772220B (zh) * | 2022-11-22 | 2023-08-11 | 武汉爱博泰克生物科技有限公司 | 针对人白介素-1β的兔单克隆抗体及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5416013A (en) * | 1990-04-04 | 1995-05-16 | Sterling Winthrop Inc. | Interleukin 1β protease and interleukin 1β protease inhibitors |
| WO1993025685A1 (en) * | 1992-06-12 | 1993-12-23 | Massachusetts Institute Of Technology | Cloning and characterization of the cell death genes ced-3 and ced-4 |
| JPH08500482A (ja) * | 1992-06-12 | 1996-01-23 | マサチューセッツ インスティテュート オブ テクノロジー | Ced−3及び関連蛋白質のインヒビター |
-
1994
- 1994-04-08 US US08/225,487 patent/US6110701A/en not_active Expired - Fee Related
-
1995
- 1995-04-04 JP JP52599295A patent/JP3750136B2/ja not_active Expired - Fee Related
- 1995-04-04 EP EP95914256A patent/EP0754234B1/en not_active Expired - Lifetime
- 1995-04-04 CA CA002187161A patent/CA2187161C/en not_active Expired - Fee Related
- 1995-04-04 ES ES95914256T patent/ES2136285T3/es not_active Expired - Lifetime
- 1995-04-04 DK DK95914256T patent/DK0754234T3/da active
- 1995-04-04 DE DE69510782T patent/DE69510782T2/de not_active Expired - Lifetime
- 1995-04-04 WO PCT/CA1995/000188 patent/WO1995027793A1/en not_active Ceased
- 1995-04-04 AT AT95914256T patent/ATE182176T1/de not_active IP Right Cessation
- 1995-04-04 US US08/721,986 patent/US6103513A/en not_active Expired - Fee Related
-
1999
- 1999-10-08 GR GR990402559T patent/GR3031468T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6103513A (en) | 2000-08-15 |
| ES2136285T3 (es) | 1999-11-16 |
| JP3750136B2 (ja) | 2006-03-01 |
| GR3031468T3 (en) | 2000-01-31 |
| EP0754234B1 (en) | 1999-07-14 |
| EP0754234A1 (en) | 1997-01-22 |
| US6110701A (en) | 2000-08-29 |
| ATE182176T1 (de) | 1999-07-15 |
| DE69510782T2 (de) | 1999-12-30 |
| CA2187161A1 (en) | 1995-10-19 |
| WO1995027793A1 (en) | 1995-10-19 |
| DE69510782D1 (de) | 1999-08-19 |
| CA2187161C (en) | 2008-02-05 |
| JPH09511646A (ja) | 1997-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE415480T1 (de) | B7l-1 moleküle | |
| ATE484587T1 (de) | Ldcam genannte moleküle | |
| FI875082A0 (fi) | Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner. | |
| ATE451462T1 (de) | Klonierung und expression von htlv-iii-dns | |
| EP0653940A4 (en) | GLIALMITOGENIC FACTORS, THEIR PRODUCTION AND USE. | |
| CA2228635A1 (en) | Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods | |
| ATE341627T1 (de) | Als lerk6 bezeichnetes cytokin | |
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| DE69738653D1 (de) | Klonierung und charakterisierung von napsin, einer aspartat-protease | |
| DK0759079T3 (da) | DNA der koder precursor for interleukin-1beta-omdannende enzym-beslægtet cysteinproteinase III (ICErel-III) | |
| BR9510408A (pt) | Aperfeiçoamento na ou relativos á função endometrial | |
| ATE304595T1 (de) | Lichtproduzierender biosensor | |
| PT83255B (pt) | Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus | |
| DK0754234T3 (da) | DNA der koder precursor for interleukin-1beta-omdannende enzymbeslægtet cycteinproteinase II (ICErel-II) | |
| ATE350472T1 (de) | Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen | |
| DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
| DE69405230D1 (de) | Prostaglandinrezeptor ep1 kodierende dna | |
| EP0785716A4 (en) | CYTOKIN DESCRIBED AS LERK6 | |
| HUP9701904A2 (hu) | D-panolakton hidroláz és az azt kódoló gén | |
| EA199900256A1 (ru) | Нуклеотидная и белковая последовательность маммастатина и способы применения | |
| NO985742L (no) | IL-1/TNF-<alfa>-aktivert kinase (ITAK) og fremgangsmÕter for fremstilling og anvendelse av denne | |
| Koj et al. | Substrate specificity and modifications of the active centre of elastase-like neutral proteinases from horse blood leucocytes | |
| WO2004060867A3 (en) | Secreted protein factor and cell membrane-bound splice variant | |
| ATE302282T1 (de) | Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen | |
| ATE275207T1 (de) | Dna zur abschätzung des progressionspotentials von zervixläsionen |